Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    intrepid
Show Display Options
Rank Status Study
1 Completed
Has Results
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
Conditions: AMD;   Wet AMD;   Age-Related Macular Degeneration;   Wet Age-Related Macular Degeneration;   Macular Degeneration;   Eye Diseases;   Retinal Diseases
Intervention: Device: IRay
2 Recruiting The Influence of Heel Wedge Properties on Roll-over of the Intrepid Dynamic Exoskeletal Orthosis (IDEO)
Condition: Physical Disability
Intervention: Device: Heel Cushion Material Bulk (foam)
3 Recruiting Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: Deep Brain Stimulation
4 Completed Correlations Phenotype / Genotype in Down Syndrome
Condition: Down Syndrome
5 Terminated Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
Condition: Myocardial Injury
Interventions: Drug: ticagrelor;   Drug: aspirin
6 Withdrawn Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Inhaled treprostinil;   Drug: Placebo
7 Completed Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Technique
Condition: Heart Failure
Intervention: Device: Cardiac Resynchronization Therapy implant
8 Completed Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Behavioral: relaxation with virtual reality (VR);   Behavioral: relaxation and biofeedback virtual reality
9 Completed Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC
Condition: Brain Injuries
Intervention: Drug: NNZ-2566
10 Completed Study of NNZ-2566 in Patients With Traumatic Brain Injury
Condition: Brain Injuries
Intervention: Drug: NNZ-2566
11 Withdrawn Inhaled Treprostinil for PAH: Open-label Extension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: inhaled treprostinil
12 Recruiting Comparison of Centurion® Vision System With Balanced Tip and the Infiniti® Vision System With the Mini Flared Kelman (MFK) Tip During Cataract Extraction Surgery of Hard Lenses
Condition: Cataracts
Interventions: Device: Centurion® Vision System, 45° Balanced Tip;   Device: Centurion® Vision System, 45° MFK Tip;   Device: lnfiniti® Vision System, 45° MFK Tip;   Device: INTREPID® Ultra infusion sleeve;   Device: Ultra infusion sleeve
13 Completed An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: cortexolone 17α-propionate
14 Completed A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: CB-03-01;   Drug: Vehicle
15 Completed Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
Conditions: Migraine;   Headache;   Classic Migraine;   Common Migraine
Intervention: Drug: Topiramate
16 Active, not recruiting PRIORITI-MTF Study- Testing Patient Response to the IDEO
Conditions: Leg Injuries;   Trauma
Intervention: Device: IDEO brace
17 Recruiting Transcranial Magnetic Stimulation (TMS) to Treat mTBI and PTSD
Conditions: Traumatic Brain Injury;   Post-Traumatic Stress Disorder
Interventions: Device: Transcranial Magnetic Stimulation;   Device: Sham Transcranial Magnetic Stimulation
18 Enrolling by invitation The Effect of Gait Training Using Virtual Reality and Real-Time Feedback on Physiological and Functional Gait Performance in Persons With a Traumatic Lower Extremity Amputation
Condition: Elevated Metabolic Cost
Intervention: Other: Gait Training
19 Enrolling by invitation Amputee Gait Training Using Virtual Reality and Real-Time Feedback
Condition: Abnormal Gait Kinematics
Intervention: Other: Gait Training
20 Recruiting Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer
Condition: Post Traumatic Stress Disorder
Interventions: Drug: DCS (D-Cycloserine ) + Prolonged Imaginal Exposure;   Drug: DCS (D-Cycloserine ) + Virtual Reality Exposure;   Drug: Placebo + Prolonged Imaginal Exposure;   Drug: Placebo (sugar pill) + Virtual Reality Exposure

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years